Search Results - "Askill, C."

A CaBER computational–experimental rheological study on human sputum by Tabatabaei, S., Jahromi, H.T., Webster, M.F., Williams, P.R., Holder, A.J., Lewis, K.E., Davies, G.A., Griffin, L., Ebden, P., Askill, C.

“…•Sputum rheological behaviour tractable via filament stretching.•Sputum, represented by kinetic and micellar theory, in developing COPD-biomarker.•Comparisons…”
Get full text

Stridor: an unexpected complication from chemoradiotherapy for anal cancer by Moe, M M, Askill, C

“…The treatment of choice for anal cancer is chemoradiotherapy. Skin reaction and bowel symptoms such as tenesmus, diarrhoea and bleeding are common side…”
Get full text

Virtual multidisciplinary teams for cancer care by Axford, A T, Askill, C, Jones, A J

“…A recent report on cancer services in Wales recommended an integrated cancer service. The proposed model was difficult to introduce in rural areas, where…”
Get more information

Pilot Study of Preoperative Combined Modality Treatment for Locally Advanced Operable Oesophageal Carcinoma: Toxicities and Long-term Outcome by Mukherjee, S., Abraham, J., Brewster, A., Hardwick, R., Havard, T., Lewis, W., Askill, C., Manson, J., Williams, G.T., Roberts, S.A., Court, J., Crosby, T.

“…Paclitaxel, a radiosensitiser, has significant activity in oesophageal cancer. We aimed to conduct a feasibility study of preoperative chemoradiation using…”
Get full text

Determinants of survival following pelvic exenteration for primary rectal cancer by Radwan, R. W., Jones, H. G., Rawat, N., Davies, M., Evans, M. D., Harris, D. A., Beynon, J.

“…Background Pelvic exenteration is a potentially curative treatment for locally advanced primary rectal cancer. Previous studies have been limited by small…”
Get full text

Outcomes in locally advanced rectal cancer with highly selective preoperative chemoradiotherapy by Williamson, J. S., Jones, H. G., Davies, M., Evans, M. D., Hatcher, O., Beynon, J., Harris, D. A.

“…Background This study compared outcomes after surgery alone for stage II/ III rectal cancer in a tertiary cancer unit versus highly selective use of…”
Get full text

365PER, PR & HER2 EXPRESSION AND SURVIVAL OF BREAST CANCER PATIENTS WITH BRAIN METASTASES (BRM) TREATED WITH WHOLE BRAIN RADIOTHERAPY (WBRT) +/- SYSTEMIC THERAPY - SINGLE CENTRE EXPERIENCE by Moe, M.M.M., Durrani, S., Bertelli, G., Pudney, D., Rolles, M., Askill, C., Wagstaff, J., Vigneswaran, V., Rowley, K., Parker, K., Hatcher, O., Phan, M., Gwynne, S., Banner, R., Thayabaran, D., Saiyed, A., Taylor, R.

“…Abstract Aim: To evaluate the impact of ER, PR and HER2 expression on survival of breast cancer patients who developed symptomatic BrM treated with WBRT with…”
Get full text

Er, Pr & Her2 Expression and Survival of Breast Cancer Patients with Brain Metastases (Brm) Treated with Whole Brain Radiotherapy (Wbrt) +/- Systemic Therapy - Single Centre Experience by Moe, M.M.M., Durrani, S., Bertelli, G., Pudney, D., Rolles, M., Askill, C., Wagstaff, J., Vigneswaran, V., Rowley, K., Parker, K., Hatcher, O., Phan, M., Gwynne, S., Banner, R., Thayabaran, D., Saiyed, A., Taylor, R.

Get full text

Orbital metastasis due to interval lobular carcinoma of the breast: a potential mimic of lymphoma by Wolstencroft, S J, Hodder, S C, Askill, C F, Sugar, A W, Jones, E W, Griffiths, A P

“…A 53-year-old woman had an orbital mass composed of a neoplastic small round cell infiltrate and no apparent extraorbital primary tumor. Although the initial…”
Get more information

Stridor: an unexpected complication from chemo- radiotherapy for anal cancer by Moe, MM, Askill, C

Get full text

Treatment of advanced head and neck cancer using synchronous therapy with methotrexate and irradiation by Pointon, R C, Askill, C, Hunter, R D, Wilkinson, P M

“…A pilot study of synchronous methotrexate and radiation therapy was carried out in 50 patients with advanced carcinoma of the head and neck, of whom 48 were…”
Get more information

Treatment of advanced head and neck carcinoma with synchronous irradiation and methotrexate by Pointon, R C, Askill, C S, Hunter, R D, Wilkinson, P M

“…Thirty-four patients with advanced head and neck cancer were treated by synchronous radiotherapy and methotrexate (MTX) (100 mg/m2). Complete resolution of…”
Get more information